Safety and efficacy of Berberis integerrima root extract in patients with type 2 diabetes. A parallel intervention based triple blind clinical trial

[1] Najafipour H(2015)Epidemiology of diabetes mellitus, pre-diabetes, undiagnosed and uncontrolled diabetes and its predictors in general population aged 15 to 75 years: a community-based study (KERCADRS) in southeastern Iran J Diabetes 7 613-621

[2] Sanjari M(2012)Diabetes mellitus: an overview on its pharmacological aspects and reported medicinal plants having antidiabetic activity Asian Pac J Trop Biomed 2 411-420

[3] Shokoohi M(2007)Possible involvment of L-argenune-nitric oxide(NO)-cyclic guanosine monophosphate (c-GMP)signaling pathway in the antidepressant activity of berbeine choloride Eur J Pharmacol 13 77-83

[4] Haghdoost AA(2018)The barberry juice effects on metabolic factors and oxidative stress in patients with type 2 diabetes: a randomized clinical trial Complement Ther Clin Pract 31 170-174

[5] Afshari M(2019)Metabolic effect of berberine–silymarin association: a meta-analysis of randomized, double-blind, placebo-controlled clinical trials Phytother Res 33 862-870

[6] Shadkam M(2009)Antihyperglycemic activity of root of Berberis aristata D.C. in alloxan-induced diabetic rats Int J Green Pharm 3 259-262

[7] Patel D(2011)Diagnosis and classificationof diabetes mellitus Diabet Care Journal 34 15-16

[8] Kumar R(2011)Hypoglycemic effect of methanolic extract of Berberis aristata DC stem on normal and streptozotocin induced diabetic rats Int J Pharm Pharm Sci 3 222-224

[9] Laloo D(2010)CONSORT 2010 statement: updated guidelines for reporting parallel group randomized trials Ann Intern Med 152 726-732

[10] Hemalatha S(2010)Blood glucose lowering potential of stem bark of Berberis aristata Dc in Alloxan- induced Diabetic rats Iranian Journal of Pharmacology & Therapeutics 9 21-24

[1] Najafipour H(2015)Epidemiology of diabetes mellitus, pre-diabetes, undiagnosed and uncontrolled diabetes and its predictors in general population aged 15 to 75 years: a community-based study (KERCADRS) in southeastern Iran J Diabetes 7 613-621

[2] Sanjari M(2012)Diabetes mellitus: an overview on its pharmacological aspects and reported medicinal plants having antidiabetic activity Asian Pac J Trop Biomed 2 411-420

[3] Shokoohi M(2007)Possible involvment of L-argenune-nitric oxide(NO)-cyclic guanosine monophosphate (c-GMP)signaling pathway in the antidepressant activity of berbeine choloride Eur J Pharmacol 13 77-83

[4] Haghdoost AA(2018)The barberry juice effects on metabolic factors and oxidative stress in patients with type 2 diabetes: a randomized clinical trial Complement Ther Clin Pract 31 170-174

[5] Afshari M(2019)Metabolic effect of berberine–silymarin association: a meta-analysis of randomized, double-blind, placebo-controlled clinical trials Phytother Res 33 862-870

[6] Shadkam M(2009)Antihyperglycemic activity of root of Berberis aristata D.C. in alloxan-induced diabetic rats Int J Green Pharm 3 259-262

[7] Patel D(2011)Diagnosis and classificationof diabetes mellitus Diabet Care Journal 34 15-16

[8] Kumar R(2011)Hypoglycemic effect of methanolic extract of Berberis aristata DC stem on normal and streptozotocin induced diabetic rats Int J Pharm Pharm Sci 3 222-224

[9] Laloo D(2010)CONSORT 2010 statement: updated guidelines for reporting parallel group randomized trials Ann Intern Med 152 726-732

[10] Hemalatha S(2010)Blood glucose lowering potential of stem bark of Berberis aristata Dc in Alloxan- induced Diabetic rats Iranian Journal of Pharmacology & Therapeutics 9 21-24